Substance / Medication

Spironolactone

Overview

Active Ingredient
spironolactone
RxNorm CUI
9997
Labeler: NuCare Pharmaceuticals,Inc.Updated: 2026-02-25T00:00:00.000ZFull label on DailyMed

Contraindications

When this intervention should not be used

Spironolactone is contraindicated in the patients with: Hyperkalemia Addison’s disease Concomitant use of eplerenone

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Detailed dosage and administration information is available in the full FDA drug label.

View full prescribing information on DailyMed

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

Clinical Trials

16 trials linked to this intervention

16
Total Trials
3
Recruiting
2
With Results

Research Evidence

Published studies and systematic reviews

Sort:
Efficacy of different topical spironolactone treatments for acne vulgaris: A meta-analysis.
Huang Wenyu, Tian Chao, Lin Bowen et al. · Pak J Pharm Sci · 2026
PMID: 41546576Meta-Analysis
Eplerenone and Spironolactone for Chronic Central Serous Chorioretinopathy: A Systematic Review and Meta-Analysis.
Huang Ryan S, Mihalache Andrew, Benour Ali et al. · Am J Ophthalmol · 2025
PMID: 40513762Meta-Analysis
Oral and topical spironolactone in acne treatment: A meta-analysis of effectiveness and safety.
AlEdani Esraa M, Abo Zeid Mohamed, Khalefa Kareem et al. · Naunyn Schmiedebergs Arch Pharmacol · 2025
PMID: 39878821Meta-Analysis
Efficacy and safety of Spironolactone in treating patients with acne vulgaris: a systematic review and meta-analysis of 1,086 patients.
Farrag Mohamed, Abo Elnaga Ahmed A, Alsaied Mohamed A et al. · Arch Dermatol Res · 2025
PMID: 39891744Meta-Analysis
Spironolactone for the Treatment of Moderate to Severe Acne in Adult Women: A Systematic Review and Meta-Analysis of Randomised Controlled Trials.
Kow Chia Siang, Ramachandram Dinesh Sangarran, Hasan Syed Shahzad et al. · Australas J Dermatol · 2025
PMID: 39912292Meta-Analysis
Comparative effectiveness and safety of eplerenone and spironolactone in patients with heart failure: a systematic review and meta-analysis.
Elshahat Ahmed, Mansour Ahmed, Ellabban Mohamed et al. · BMC Cardiovasc Disord · 2024
PMID: 39271992Meta-AnalysisFull text (PMC)
The efficacy of Topical Clascoterone versus systematic spironolactone for treatment of acne vulgaris: A systematic review and network meta-analysis.
Basendwh Mohammad A, Alharbi Amer Abdulaziz, Bukhamsin Sarah Abdulla et al. · PLoS One · 2024
PMID: 38814916Meta-AnalysisFull text (PMC)
Do Pleiotropic Effects of Spironolactone in Women with PCOS Make it More than an Anti-androgen? Evidence from a Systematic Review and Meta-analysis.
Bashir Rohina, Asrar Mir Mahmood, Shah Idrees Ayoub et al. · Curr Pharm Des · 2023
PMID: 36999713Meta-Analysis
Role of topical spironolactone in the treatment of acne: A systematic review of clinical trials-Does this therapy open a path towards favorable outcomes?
Rehan Syeda Tayyaba, Khan Zayeema, Abbas Samina et al. · J Dermatol · 2023
PMID: 36412248Meta-Analysis

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Adverse reaction and safety data for this drug is sourced from the FDA-approved label.

View adverse reactions & drug interactions on DailyMed

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Health Goals

Goals connected through associated conditions

Quick Facts

Type
Substance / Medication
Fully Specified Name
Spironolactone (substance)
SNOMED CT
387078006
UMLS CUI
C0037982
RxNorm CUI
9997
Labeler
NuCare Pharmaceuticals,Inc.

Clinical Data

This intervention maps to 16 entities in the Ltrl knowledge graph.

6
Conditions
5
Biomarkers
3
Specialists
0
Symptoms
16
Clinical Trials

Data is sourced from SNOMED CT, UMLS, and the Ltrl clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.